Glasgow/Wetlab

From 2007.igem.org

< Glasgow(Difference between revisions)
 
(256 intermediate revisions not shown)
Line 1: Line 1:
-
{|cellspacing="6px" cellpadding="16" border="0" width="100%"
+
{| valign=top cellpadding=3
|-
|-
-
[[Glasgow/Wetlab/Protocols|PROTOCOLS]]
+
!align=center|[[Image:Uog.jpg]] ||    ||  [[Glasgow|<font face=georgia color=#3366CC size=4>Back To <br> Glasgow's <br> Main Page</font>]] || [[Glasgow/Modeling|<font face=georgia color=#3366CC size=4>Go To <br> Glasgow's <br> Modelling Page</font>]]
-
[[Glasgow/Wetlab/References|REFERENCES]]
+
|}
 +
----
 +
{|cellspacing="6px" cellpadding="16" border="0" width="100%"
 +
|- align=center
 +
|[https://2007.igem.org/Glasgow/Wetlab/Protocols <font face=georgia color=#3366CC size=5><b>Protocols</b></font>]
 +
|[https://2007.igem.org/Glasgow/Wetlab/References <font face=georgia color=#3366CC size=5><b>References</b></font>]
 +
|[https://2007.igem.org/Glasgow/Wetlab/Resources <font face=georgia color=#3366CC size=5><b>Resources</b></font>]
 +
|[https://2007.igem.org/Glasgow/Wetlab/Orders <font face=georgia color=#3366CC size=5><b>Sequences</b></font>]
 +
|[https://2007.igem.org/Glasgow/Wetlab/Biobricks <font face=georgia color=#3366CC size=5><b>Biobricks<br>Used</b></font>]
 +
|[https://2007.igem.org/Glasgow/Wetlab/Gels <font face=georgia color=#3366CC size=5><b>Gels</b></font>]
|}
|}
-
== Week 1 ==
 
-
=== 03/07 ===
 
-
#Maija and Christine prepared LB broth and LB agar with Protocol 1.  Made 4 batches of plates, 2 with kanamycin and 2 with carbenicillin.
 
-
=== 04/07 ===
+
----
-
#All wetlab researched BioBricks.
+
-
#Reporter constructs and mini-Tn5 stocks looked out.
+
-
#Streaked the following:
+
-
##P. putida PAW 340 pJAK14 (Carb. plate)
+
-
##Tn5 lux AB (Carb. plate)
+
-
##Mini-Tn5 lux AB (Carb. plate)
+
-
##P. Fluorescens NCIMB 9815 (Carb. plate)
+
-
##P. putida KT2440 (LB)
+
-
##JM109 pBluescript 5k+ (Carb. plate)
+
-
##Mini-Tn5 Tc (Carb. Plate)
+
-
##pQF52 (Carb. plate)
+
-
##P. Fluorescens 9815 (LB)
+
-
##E. coli pJAK14 (Km plate)
+
-
##Il DntR in pOF52 (Carb. plate)
+
-
##pUCINR in Ω strain C (Carb. plate)
+
-
##pGLTUR (Carb. plate)
+
-
##Mini-Tn5 Kan (Carb. plate)
+
-
##Mini-Tn5 Sm/Sp (Carb. plate)
+
-
##Mini-Tn5 1cc2 (Carb. plate)
+
-
##E. coli Sa1 (LB)
+
-
##DmpR #24 (Carb. plate)
+
-
##Mini-Tn5 lac 32 in E. coli 517 (Carb. plate)
+
-
##Mini-Tn5 Tc (Carb. Plate)
+
-
##Mini-Tn5 Cm (Carb. plate)
+
-
##DmpR WT (Carb. plate)
+
-
##E.coli sm 10 pESD15 Tn5 GFP (Carb. plate)
+
-
##pUJ8 (Carb. Plate)
+
-
=== 05/07 ===
+
''Click on a week number for more detailed lab book...''
-
#BioBricks – Maija and Scott transformed using Protocol 2.
+
-
#*BBa_p1010 (DB3.1) (death gene plasmid) Plate 4: 7A – p5B1A10, 11E – p5B1A10 and 11C – p5B3K3
+
-
#*BBa_IS2001 (Top10) (high copy number plasmid) Plate 4: 5I – p5B4A5, 5D – p5B4K5, 6B – p5B3K5, 6D – p5B4K5 and 6E – p5B4A5 (Also 5K, 5M, 4J, 4L, 4N, 4P)
+
-
#*BBa_J23119 (Top 10) (strong constitutive promoter) Plate 3: 19A – pB1A2 (V1013)
+
-
#*BBa_R0062 (Top 10) (HSL and luxR inducible) Plate 1: 9G – pSB1A2 (V1004)
+
-
#*BBa_J04500 (Top 10) (IPTG inducible prom + RBS) Plate 1: 16P – p5B1AK3 (V1009)
+
-
#*BBa_E0040 (Top 10) (GFP mutant no promoter (3b)) Plate 1: 5H – p5B1A2 (V1001)
+
-
#Maia and Christine researched restriction enzymes for the reporter constructs and Mini-Tn5s streaked on 4/7/07 and digested some. Had planned to make biobricks using Mini-Tn5s etc but discovered that a previous attempt to use transposable elements to make biobricks had been unsuccessful due to scarring at the restriction site. http://partsregistry.org/Part:BBa_J61206
+
-
=== 06/07 ===
 
-
#Maija and Christine made 10x stocks for M9 (see Protocol 3).
 
-
#Tutorial in BioEdit and Primer3.
 
-
#Started designing primers for amplification and site directed mutagenesis of DmpR and DmpR #24 (see Protocol 4).
 
-
=== 09/07 ===
+
{|cellspacing="6px" cellpadding="16" border="0" width="100%"
-
#Christine and Maija designed primers for site directed mutagenesis in DmpR, DmpR #24, ****, **** and ****, and amplification of DmpR and DmpR #24.  Used Protocol 4, and to check Tm http://www.itt-biotech.de/itt-cgi/oligo-tm.pl
+
|- align="center"
-
#Mai carried out restriction digests of DmpR and DmpR #24.  Results were poor and gel gave poor visibility.
+
!width="50%" | [https://2007.igem.org/Glasgow/Wetlab/Week1 <font face=georgia color=#3366CC size=7><b>Week 1</b></font>] <br>
-
#Scott retransformed any of the transformations that did not work from the transformations from 5/7/07.
+
-
#*4/11C BBa_p1010 pSB3K3 death gene
+
-
#*4/5I BBa_I522001 pSB4A5 hi-copy
+
-
#*4/5D BBa_I522001 pSB4K5 hi-copy
+
-
#*4/6B BBa_I522001 pSB3K3 hi-copy
+
-
#*4/6D BBa_I522001 pSB4K hi-copy
+
-
#*1/5H BBa_E0040 pSB1A2 GFP non promoter
+
-
#Used transformations that did work and set them up tubes of LB for minipreps tomorrow.
+
-
#*BBa_I52001 death gene plasmid (hi copy number)
+
-
#*BBa-J23119 strong constitutive promoter
+
-
#*BBa_R0062 HSL and luxR inducible
+
-
#*BBa_306500 IPTG inducible and RBS
+
-
Plan is to use DmpR and DmpR #24 to detect phenol and produce lacZ.  Grown on Xgal the better the bacteria detect phenol, the more blue they will be in a spectrophotometer.
+
-
=== 10/07 ===
+
!width="50%" |[https://2007.igem.org/Glasgow/Wetlab/Week2 <font face=georgia color=#3366CC size=7><b>Week 2</b></font>] <br>
-
#Mai did minipreps, according to Quiagen prepkit manual (see Protocol 5), of the transformations grown in LB last night (9/7/07).
+
 
-
#Wetlab and Drylab gave presentations to the team to explain key terms used in the lab (see Tutorials).
+
|- valign=top
-
#Christine made tetracycline stock – 250 mg tetracycline in 50ml 100% ethanol to make 5mg/ml stock.
+
|
-
#Maija made thiamine stock (0.8g thiamine in 20ml dH2O and filter sterilized. Kept in freezer in foil (light sensitive).
+
*'''First selection of biobricks transformed.'''
-
#Christine grew E. coli pJAK14 in LB overnight at 37°C following protocol from Wise et al, 2000).
+
*'''Preparation of stocks.'''
-
#Scott and Lynsey grew DmpR and DmpR #24 overnight in LB with Tc and Carb. This is because the plates streaked on 4/7/07 (3.)  for DmpR and DmpR #24 did not grow, and restriction digests on 9/7/07 (2.) used up most of the DNA. What is grown will be mini-prepped and restriction digested tomorrow.
+
|
-
#*2x  5ml LB containing carb (50ug/ml) with DmpR
+
*'''Researched DmpR, XylR and DntR sensor systems.'''
-
#*2x  5ml LB containing carb (50ug/ml) with DmpR #24
+
*'''Designed primers for DmpR, DntR, XylR and associated promoters.'''
-
#*2x  5ml LB containing Tc (50ug/ml) with DmpR
+
 
-
#*2x  5ml LB containing Tc (50ug/ml) with DmpR #24
+
|- align="center"
-
#*2x  5ml LB containing Tc (10ug/ml) with DmpR
+
!width="50%" |[https://2007.igem.org/Glasgow/Wetlab/Week3 <font face=georgia color=#3366CC size=7><b>Week 3</b></font>] <br>
-
#*2x  5ml LB containing Tc (10ug/ml) with DmpR #24
+
 
-
#Scott's retransformations (9/7/07) all worked (esp Top 10s, not so much DB3.1). To be mini-prepped tomorrow.
+
!width="50%" |[https://2007.igem.org/Glasgow/Wetlab/Week4 <font face=georgia color=#3366CC size=7><b>Week 4</b></font>] <br>
 +
 
 +
|- valign=top
 +
|
 +
*'''BioBricks tested by digestion and PCR.'''
 +
*'''PCR with new primers associated with DntR and XylR.'''
 +
|
 +
* '''phzM and phzS cloned into TOPO vectors.'''
 +
*'''Primer design for 7 gene operon.'''
 +
*'''DntR cloned into TOPO vector.'''
 +
*'''Primer design for XylR and associated genes.'''
 +
*'''Death gene cloned into TOPO vector.'''
 +
*'''Primer design for death gene.'''
 +
 
 +
|- align="center"
 +
!width="50%" |[https://2007.igem.org/Glasgow/Wetlab/Week5 <font face=georgia color=#3366CC size=7><b>Week 5</b></font>] <br>
 +
 
 +
!width="50%" |[https://2007.igem.org/Glasgow/Wetlab/Week6 <font face=georgia color=#3366CC size=7><b>Week 6</b></font>] <br>
 +
 
 +
|- valign=top
 +
|
 +
*'''Suspected amplification of 7 gene operon.'''
 +
* '''phzM and phzS confirmed as present in TOPO vectors.'''
 +
*'''Confirmed presence of death gene plasmid in some vectors.'''
 +
*'''Miller assay performed with DntR system.'''
 +
*'''Yeast cells.'''
 +
|
 +
*'''Biobricks made of phzM, phzS, and DntR.'''
 +
 
 +
|- align="center"
 +
!width="50%" |[https://2007.igem.org/Glasgow/Wetlab/Week7 <font face=georgia color=#3366CC size=7><b>Week 7</b></font>] <br>
 +
 
 +
!width="50%" |[https://2007.igem.org/Glasgow/Wetlab/Week8 <font face=georgia color=#3366CC size=7><b>Week 8</b></font>] <br>
 +
 
 +
|- valign=top
 +
|
 +
*'''Utilised new biobricks.'''
 +
*'''Site directed mutagenesis of phzM completed.'''
 +
|
 +
*'''Site directed mutagenesis of phzS completed.'''
 +
 
 +
 
 +
|- align="center"
 +
!width="50%" |[https://2007.igem.org/Glasgow/Wetlab/Week9 <font face=georgia color=#3366CC size=7><b>Week 9</b></font>] <br>
 +
 
 +
!width="50%" |[https://2007.igem.org/Glasgow/Wetlab/Week10 <font face=georgia color=#3366CC size=7><b>Week 10+</b></font>] <br>
 +
 
 +
|- valign=top
 +
|
 +
*'''phzD→phzG successfully cloned into TOPO vector.'''
 +
|
 +
*'''Contains further work achieved.'''
 +
*'''XylR and Pr cloned into construction vectors.'''
 +
*'''XylR and Pr put next to responsive promoter and luciferase.'''
 +
|}
 +
 
 +
----
 +
 
 +
{|cellspacing="6px" cellpadding="16" border="0" width="100%"
 +
|- align=center
 +
|[https://2007.igem.org/Glasgow/Wetlab/Protocols <font face=georgia color=#3366CC size=5><b>Protocols</b></font>]
 +
|[https://2007.igem.org/Glasgow/Wetlab/References <font face=georgia color=#3366CC size=5><b>References</b></font>]
 +
|[https://2007.igem.org/Glasgow/Wetlab/Resources <font face=georgia color=#3366CC size=5><b>Resources</b></font>]
 +
|[https://2007.igem.org/Glasgow/Wetlab/Orders <font face=georgia color=#3366CC size=5><b>Orders</b></font>]
 +
|[https://2007.igem.org/Glasgow/Wetlab/Biobricks <font face=georgia color=#3366CC size=5><b>Biobricks<br>Used</b></font>]
 +
|[https://2007.igem.org/Glasgow/Wetlab/Gels <font face=georgia color=#3366CC size=5><b>Gels</b></font>]
 +
|}

Latest revision as of 11:54, 26 October 2007

Uog.jpg Back To
Glasgow's
Main Page
Go To
Glasgow's
Modelling Page

Protocols References Resources Sequences Biobricks
Used
Gels

Click on a week number for more detailed lab book...


Week 1
Week 2
  • First selection of biobricks transformed.
  • Preparation of stocks.
  • Researched DmpR, XylR and DntR sensor systems.
  • Designed primers for DmpR, DntR, XylR and associated promoters.
Week 3
Week 4
  • BioBricks tested by digestion and PCR.
  • PCR with new primers associated with DntR and XylR.
  • phzM and phzS cloned into TOPO vectors.
  • Primer design for 7 gene operon.
  • DntR cloned into TOPO vector.
  • Primer design for XylR and associated genes.
  • Death gene cloned into TOPO vector.
  • Primer design for death gene.
Week 5
Week 6
  • Suspected amplification of 7 gene operon.
  • phzM and phzS confirmed as present in TOPO vectors.
  • Confirmed presence of death gene plasmid in some vectors.
  • Miller assay performed with DntR system.
  • Yeast cells.
  • Biobricks made of phzM, phzS, and DntR.
Week 7
Week 8
  • Utilised new biobricks.
  • Site directed mutagenesis of phzM completed.
  • Site directed mutagenesis of phzS completed.


Week 9
Week 10+
  • phzD→phzG successfully cloned into TOPO vector.
  • Contains further work achieved.
  • XylR and Pr cloned into construction vectors.
  • XylR and Pr put next to responsive promoter and luciferase.

Protocols References Resources Orders Biobricks
Used
Gels